Stay updated on Filgotinib in Small Bowel Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Filgotinib in Small Bowel Crohn's Disease Clinical Trial page.

Latest updates to the Filgotinib in Small Bowel Crohn's Disease Clinical Trial page
- Check5 days agoChange DetectedThe NIH transition announcement about using “Super Intelligence” in place of “Artificial Intelligence” is no longer shown. The study page continues to display a 403 error.SummaryDifference1%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide NIH notice appears above the 403 error, announcing a website transition and a terminology change from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2. The page continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, indicating an access restriction to view the content. This reflects a permissions issue rather than a content update on the trial page.SummaryDifference0.5%

Stay in the know with updates to Filgotinib in Small Bowel Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib in Small Bowel Crohn's Disease Clinical Trial page.